Navigation Links
Premier Research Names Etienne Drouet Executive Director, Oncology Europe
Date:1/23/2012

PHILADELPHIA, Jan. 23, 2012 /PRNewswire/ -- Premier Research Group announces the appointment of Etienne Drouet to the position of Executive Director, Oncology Europe. In this position, Mr. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research's growing portfolio of oncology business.

"Etienne brings a tremendous amount of operational knowledge and oncology acumen serving the needs of our customers," said Dr. Sue Stansfield, Executive VP, Clinical Development.  Dr. Ludo Reynders added, "Having worked with Etienne before, I am pleased to have someone of his caliber lead our European oncology team."

Mr. Drouet offers practical insight to oncology clinical trials with more than 19 years in drug development including 14 years in clinical research and five years as a research scientist. Mr. Drouet has held positions of increasing responsibility at pharmaceutical, contract research, and investigational cooperative groups including Rhone Poulenc Rorer (Sanofi Aventis), Icon, and Breast Cancer International Research Group. His extensive oncology experience and expertise has ensured timely, efficient program delivery. He holds a Biotechnology Engineering degree from the European Engineering School of Biotechnology and a Master in Science degree from the University Louis Pasteur.

About Premier Research
Premier Research is a professional services company providing clinical development services to the pharmaceutical, biotechnology, and medical device industries. Founded in 1989 and headquartered in Philadelphia, USA, the company has 21 offices across North America and Europe and operates in over 30 countries worldwide.  The company is a leader in performing clinical research in the analgesia, oncology, pediatrics, medical device and neurosciences areas. Additionally, it provides a strong strategic sourcing group that supports customers in their resource planning and management.

The company offers a comprehensive series of services for every phase of clinical development including, regulatory affairs, clinical trial management, medical affairs and strategic consulting, pharmacovigilance, data operations, biostatistics, medical writing, interactive response technologies, and quality assurance.

For more information please visit, www.premier-research.com.

 

    


'/>"/>
SOURCE Premier Research Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Premier Research Names Susan Stansfield, PhD Executive VP, Clinical Development
2. "Wells Pharmacy Network" a Premier Compounding Pharmacy Focused on Serving the Unique Needs of the Medical and Veterinarian Communities Opens in Wellington
3. The Huntington Medical Foundation -- Pasadenas Premier Medical Group
4. SurgiCount Medical Announces Agreement with Premier Healthcare Alliance
5. White Smile Global Inc. Corporate Update on the White Smile Premier™ "At-Home" LED Teeth Whitening System and the White Smile Tooth Gloss™, Including Clinical Study, Product Manufacturing, and Distribution
6. SensoScientific Awarded Contract by Premier Health Care Alliance for its Breakthrough WI-FI Temperature Monitoring System
7. MAQUET Cardiovascular Awarded Three-Year Contract From Premier Healthcare Alliance for Intra-Aortic Balloon Pumps
8. Qmed - The Premier Source for OEMs Seeking Suppliers and Products in Medical Device Industry - Reconfirms its Leadership with the Highest Traffic Month to Date
9. Life Recovery Systems Awarded Contract With Premier for Patient Temperature Management
10. Premier Awards Sixth Consecutive Contract to Instrumentation Laboratory for Critical Care Portfolio
11. ARKRAY Awarded Blood Glucose Meters Agreement With the Premier Healthcare Alliance for Non-Acute Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells are ... characterized by self-renewal and the capacity to differentiate into ... new discovery, as the first mouse embryonic stem cells ... not until 1995 that the first culturing of embryonic ... cells were not produced until 2006 As a result ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. Cuomo ... create 1,400 jobs throughout Western New York ... with the SUNY Polytechnic Institute, includes a major expansion ... in Buffalo , as well as ... facility in Dunkirk . The combined ...
Breaking Medicine Technology:
(Date:2/12/2016)... , ... February 12, 2016 ... ... today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced ... will recruit top students from U.S. universities who will draw from Siemens’ ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young Asset ... celebrates the beginning of the latest charity campaign in their community enrichment program. ... Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ . ...
Breaking Medicine News(10 mins):